Authors:
Vassilakis, DA
Sourvinos, G
Pantelidis, P
Spandidos, DA
Siafakas, NM
Bouros, D
Citation: Da. Vassilakis et al., Extended genetic alterations in a patient with pulmonary sarcoidosis, a benign disease, SARCO VASC, 18(3), 2001, pp. 307-310
Authors:
Alexandrakis, MG
Kyriakou, DS
Bouros, D
Xylouri, I
Antonakis, N
Siafakas, NM
Citation: Mg. Alexandrakis et al., Interleukin-6 and its relationships to acute phase proteins in serous effusion differentiation, ONCOL REP, 8(2), 2001, pp. 415-420
Authors:
Magkanas, E
Voloudaki, A
Bouros, D
Prassopoulos, P
Alexopoulou, C
Tzanakis, N
Linardakis, M
Gourtsoyiannis, N
Citation: E. Magkanas et al., Pulmonary sarcoidosis - Correlation of expiratory high-resolution CT findings with inspiratory patterns and pulmonary function tests, ACT RADIOL, 42(5), 2001, pp. 494-501
Authors:
Mermigkis, CM
Tsakanika, K
Polychronopoulos, V
Karagianidis, N
Mermigkis, D
Bouros, D
Citation: Cm. Mermigkis et al., Expression of bcl-2 protein in bronchoalveolar lavage cell populations from patients with idiopathic pulmonary fibrosis, ACT CYTOL, 45(6), 2001, pp. 914-918
Authors:
Vassilakis, DA
Sourvinos, G
Spandidos, DA
Siafakas, NM
Bouros, D
Citation: Da. Vassilakis et al., Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis, AM J R CRIT, 162(3), 2000, pp. 1115-1119
Authors:
Alexandrakis, MG
Coulocheri, SA
Bouros, D
Mandalaki, K
Karkavitsas, N
Eliopoulos, GD
Citation: Mg. Alexandrakis et al., Evaluation of inflammatory cytokines in malignant and benign pleural effusions, ONCOL REP, 7(6), 2000, pp. 1327-1332
Authors:
Alexandrakis, MG
Coulocheri, SA
Bouros, D
Vlachonikolis, IG
Eliopoulos, GD
Citation: Mg. Alexandrakis et al., Significance of alpha-2-macroglobulin, alpha-1-acid glycoprotein, and C-reactive protein in pleural effusion differentiation, RESPIRATION, 67(1), 2000, pp. 30-35
Authors:
Petrakis, I
Katsamouris, A
Drossitis, I
Bouros, D
Chalkiadakis, G
Citation: I. Petrakis et al., Usefulness of thoracoscopic surgery in the diagnosis and management of thoracic diseases, J CARD SURG, 41(5), 2000, pp. 767-771
Authors:
Vassilakis, DA
Sourvinos, G
Markatos, M
Psathakis, K
Spandidos, DA
Siafakas, NM
Bouros, D
Citation: Da. Vassilakis et al., Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis, AM J R CRIT, 160(5), 1999, pp. 1729-1733
Authors:
Bouros, D
Schiza, S
Tzanakis, N
Chalkiadakis, C
Drositis, J
Siafakas, N
Citation: D. Bouros et al., Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema - A randomized, double-blind study, AM J R CRIT, 159(1), 1999, pp. 37-42
Authors:
Bouros, D
Bachlitzanakis, N
Kottakis, J
Pfister, P
Polychronopoulos, V
Papadakis, E
Constantopoulos, S
Froudarakis, M
Sichletidis, L
Siafakas, N
Citation: D. Bouros et al., Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma, EUR RESP J, 14(3), 1999, pp. 627-632
Authors:
Georgoulias, V
Kouroussis, C
Androulakis, N
Kakolyris, S
Dimopoulos, MA
Papadakis, E
Bouros, D
Apostolopoulou, F
Papadimitriou, C
Agelidou, A
Hatzakis, K
Kalbakis, K
Kotsakis, A
Vardakis, N
Vlachonicolis, J
Citation: V. Georgoulias et al., Front-line treatment of advanced non-small-cell lung cancer with docetaxeland gemcitabine: A multicenter phase II trial, J CL ONCOL, 17(3), 1999, pp. 914-920
Authors:
Alexandrakis, MG
Coulocheri, SA
Bouros, D
Eliopoulos, GD
Citation: Mg. Alexandrakis et al., Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions, ANTICANC R, 19(4C), 1999, pp. 3607-3612